pate to the olfactory process by odorant substance bio- Although the glucuronidation reaction occurs in lower
transformation, and act as a metabolic barrier against air- rate, when compared to that measured in liver, the UGT
borne hazardous chemicals.
expressed in nervous tissues can contribute efficiently
In conclusion, this study shows that nervous tissues to the biotransformation of these biological active sub-
are able to glucuronidate cis- and trans-resveratrol in rat. stances.
References
1 Goldberg DM, Hahn SE, Parkes JG: Beyond
alcohol-beverage consumption and cardio-
vascular mortality. Clin Chim Acta 1995;
237:155–187.
14 Virgili M, Contestabile A: Partial neuropro-
tection of in vivo excitotoxic brain damage
by chronic administration of the red wine
antioxidant agent, trans-resveratrol in rats.
Neurosci Lett 2000;281:123–126.
15 Han YS, Bastianetto S, Dumont Y, Quiron R:
Specific plasma membrane binding sites for
polyphenols, including resveratrol, in the rat
brain. J Pharmacol Exp Ther 2006;318:238–
245.
16 Han YZ, Zhen WH, Bastianetto S, Chabot
JG, Quirion R: Neuroprotective effects of
resveratrol against beta-amyloid-induced
neurotoxicity in rat hippocampal neurons:
involvement of protein kinase C. Br J Phar-
macol 2004;141:997–1005.
17 Simonyi A, Wang Q, Miller RL, Yusof M,
Shelat PB, Sun AY, Sun GY: Polyphenols in
cerebral ischemia: novel targets for neuro-
protection. Mol Neurobiol 2005;31:135–147.
18 Bastianetto S, Yao ZX, Papadopoulos V,
Quiron R: Neuroprotective effects of green
and black teas and their catechin gallate es-
ters against beta-amyloid-induced toxicity.
Eur J Neurosci 2006;23:55–64.
19 Kuhnle G, Spencer JPE, Chowrimootoo G,
Schroeter H, Debnam ES, Srai SK, Rice-Ev-
ans C, Hahn U: Resveratrol is absorbed in
the small intestine as resveratrol glucuro-
nide. Biochem Biophys Res Commun 2000;
272:212–217.
20 Radominska-Pandya A, Czernik PJ, Little J,
Battaglia E, Mackenzie PI: Structural and
functional studies of UDP-glucuronosyl-
transferases. Drug Metab Rev 1999;31:817–
899.
21 Aumont V, Krisa S, Battaglia E, Netter P,
Richard T, Mérillon JM, Magdalou J, Sabo-
lovic N: Regioselective and stereospecific
glucuronidation of trans- and cis-resveratrol
in human. Arch Biochem Biophys 2001;393:
281–289.
22 Suleman G, Abid A, Gradinaru D, Daval JL,
Magdalou J, Minn A: Identification of the
uridine diphosphate glucuronosyltransfer-
ase isoform UGT1A6 in rat brain and in pri-
mary cultures of neurons and astrocytes.
Arch Biochem Biophys 1998;358:63–67.
23 Leclerc S, Heydel JM, Amossé V, Gradinaru
D, Cattarelli M, Artur Y, Goudonnet H,
Magdalou J, Netter P, Pelczar H, Minn A:
Glucuronidation of odorant molecules in the
rat olfactory system: activity, expression and
age-linked modifications of UDP-glucuro-
nosyltransferase isoforms, UGT1A6 and
UGT2A1, and relation to mitral cell activity.
Mol Brain Res 2002;107:201–213.
24 Waffo Teguo P, Decendit A, Krisa S, Def-
fieux G, Vercauteren J and Merillon JM: The
accumulation of stilbene glycosides in Vitis
vinifera cell suspension cultures. J Nat Prod
1996;59:1189–1191.
25 Fournel-Gigleux S, Sutherland L, Sabolovic
N, Burchell B, Siest G: Stable expression of
two human UDP-glucuronosyltransferase
cDNA in V79 cell cultures. Mol Pharmacol
1991;39:177–183.
26 Pritchard M, Fournel-Gigleux S, Siest G,
Mackenzie P, Magdalou J: A recombinant
phenobarbital-inducible rat liver UDP-glu-
curonosyltransferase (UDP-glucuronosyl-
transferase 2B1) stably expressed in V 79
cells catalyses the glucuronidation of mor-
phine, phenols, and carboxylic acids. Mol
Pharmacol 1994;45:42–50.
2 McMurtrey KD: Resveratrol in wine. Acs
Sympos Series 1997;66:44–55.
3 Kopp P: Resveratrol, a phytoestrogen found
in red wine: a possible explanation for the
conundrum of the ‘French paradox’? Eur J
Endocrinol 1998;138:619–620.
4 Lin JK, Tsai SH: Chemoprevention of cancer
and cardiovascular disease by resveratrol.
Proc Natl Sci Counc Repub China 1999;23:
99–106.
5 Das DK, Maulik N: Resveratrol in cardiopro-
tection: a therapeutic promise of alternative
medicine. Mol Interv 2006;6:36–47.
6 Jang M, Pezzuto JM: Cancer chemopreven-
tive activity of resveratrol. Drugs Exp Clin
Res 1999;25:65–67.
7 Carbo N, Costelli P, Baccino FM, Lopez-So-
riano FJ, Argiles JM: Resveratrol, a natural
product present in wine, decreases tumor
growth in a rat tumor model. Biochem Bio-
phys Res Commun 1999;254:739–743.
8 Park JW, Choi YJ, Jang MA, Lee YS, Jun DY,
Suh SI, Baek WK, Suh MH, Jin IN, Kwon TK:
Chemopreventive agent resveratrol, a natu-
ral product derived from grapes, reversibly
inhibits progression through S and G2 phas-
es of the cell cycle in U937 cells. Cancer Lett
2001;163:43–49.
9 Delmas D, Passilly-Degrace P, Jannin B,
Cherkaoui-Malki M, Latruffe N: Resveratrol
a chemopreventive agent disrupts the cell cy-
cle control of human SW 480 colorectal tu-
mor cells. Int J Mol Med 2002;10:193–199.
10 Savouret JF, Quesne M: Resveratrol and can-
cer: a review. Biom Pharmacother 2002;56:
84–87.
27 Senay C, Jedlitschky G, Terrier N, Burchell
B, Magdalou J, Fournel-Gigleux S: The im-
portance of cysteine 126 in the human liver
UDP-glucuronosyltransferase
UGT1A6.
Biochem Biophys Acta 2002;1597:90–96.
28 Terrier N, Benoit E, Senay C, Lapicque F, Ra-
dominska-Pandya A, Magdalou J, Fournel-
Gigleux S: Human and rat liver UDP-glu-
curonosyltransferase are targets of keto-
profen acylglucuronide. Mol Pharmacol
1999;56:226–234.
29 Bayol-Denizot C, Daval JL, Netter P, Minn
A: Xenobiotic-mediated production of su-
peroxide by primary cultures of rat cerebral
endothelial cells, astrocytes and neurones.
Biochim Biophys Acta 2000;1497:115–126.
30 Heurtaux T, Benani A, Bianchi A, Moindrot
A, Gradinaru D, Magdalou J, Netter P, Minn
A: Redox state alteration modulates astro-
cyte glucuronidation. Free Radic Biol Med
2004;37:1051–1063.
31 Heurtaux T, Benani A, Moulin D, Muller N,
Netter P, Minn A: Induction of UGT1A6 iso-
form by inflammatory conditions in rat as-
trocytes. Neuropharmacology 2006;50:317–
328.
11 Commenges D, Scotet V, Renaud S, Jacqmin-
Gadda H, Barbeger-Gateau P, Dartigues JF:
Intake of flavonoids and risk of dementia.
Eur J Epidemiol 2000;16:357–363.
12 Bastianetto S, Quirion R: Natural extracts as
possible protective agents of brain aging.
Neurobiol Aging 2002;23:891–897.
13 Jang JH, Surh YJ: Protective effect of res-
veratrol on beta-amyloid-induced oxidative
PC12 cell death. Free Radic Biol Med 2003;
34:1100–1110.
Pharmacology 2007;80:185–192
Resveratrol Glucuronidation in Brain
Tissues
191